Paloma Partners’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-19,700
Closed -$2.88M 2348
2019
Q1
$2.88M Buy
19,700
+700
+4% +$101K 0.07% 319
2018
Q4
$258K Buy
+19,000
New +$3.11M 0.01% 928
2018
Q3
Hold
0
257
2018
Q2
Sell
-24,500
Closed -$4.12M 2403
2018
Q1
$4.12M Buy
+24,500
New +$4.11M 0.06% 255
2017
Q4
Sell
-11,300
Closed -$2.32M 2453
2017
Q3
$2.32M Sell
11,300
-49,200
-81% -$11.4M 0.03% 645
2017
Q2
$14.7M Buy
+60,500
New +$14.2M 0.17% 78
2016
Q2
Sell
-60,000
Closed -$16.1M 2418
2016
Q1
$16.1M Sell
60,000
-130,000
-68% -$37.2M 0.26% 50
2015
Q4
$59.4M Buy
+190,000
New +$56.6M 1.57% 6

Other funds holding AGN

Paloma Partners's AGN Position: Q2 2020 in Review

Paloma Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 59,966 shares — an estimated $10.6M sold.

Paloma Partners first reported a position in AGN in Q3 2013 and held it in 21 quarters. The position peaked at $30.1M in Q4 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Paloma Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Paloma Partners sold 59,966 Allergan plc shares in Q2 2020, an estimated $10.6M.
  • Paloma Partners first reported a position in Allergan plc in Q3 2013 and held it in 21 quarters.
  • Paloma Partners's Allergan plc position peaked at $30.1M in Q4 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Paloma Partners's 13F filing for Q2 2020, filed 14 Aug 2020.